Cumberland Pharmaceuticals Inc. (CPIX)

CPIX Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	21	26	33	69	44	78
Market Cap Growth	-15.16%	-21.52%	-52.94%	55.91%	-43.27%	-16.48%
Enterprise Value	24	26	34	58	37	71
PE Ratio	-	-4.07	-5.84	-19.72	-13.28	-22.10
PS Ratio	0.54	0.65	0.78	1.92	1.19	2.27
PB Ratio	0.76	0.86	0.90	1.62	0.94	1.53
P/FCF Ratio	4.17	4.53	5.10	11.55	13.44	38.38
P/OCF Ratio	3.91	4.19	3.85	10.90	8.19	25.59
EV/Sales Ratio	0.62	0.65	0.80	1.62	0.98	2.08
EV/EBITDA Ratio	-14.81	125.26	81.76	47.24	21.22	69.18
EV/EBIT Ratio	-3.47	-4.61	-6.87	-17.24	-12.15	-21.21
EV/FCF Ratio	4.78	4.55	5.29	9.72	11.11	35.09
Debt / Equity Ratio	0.79	0.62	0.58	0.38	0.36	0.42
Debt / EBITDA Ratio	-11.91	90.00	50.78	13.04	9.88	20.80
Debt / FCF Ratio	4.30	3.27	3.29	2.68	5.17	10.55
Quick Ratio	1.10	1.00	1.15	1.76	1.45	1.49
Current Ratio	1.37	1.28	1.61	2.37	1.95	2.08
Asset Turnover	0.46	0.45	0.45	0.41	0.39	0.32
Interest Coverage	-12.95	-8.33	-8.39	-34.42	-11.46	-13.69
Return on Equity (ROE)	-25.90%	-18.10%	-14.30%	-7.60%	-6.90%	-6.70%
Return on Assets (ROA)	-9.90%	-7.20%	-6.00%	-4.00%	-3.40%	-3.30%
Return on Capital (ROIC)	-20.13%	-19.89%	-9.97%	-13.04%	-9.96%	-12.79%
Earnings Yield	-40.08%	-24.58%	-17.12%	-5.07%	-7.53%	-4.52%
FCF Yield	23.99%	22.08%	19.60%	8.66%	7.44%	2.61%
Buyback Yield / Dilution	3.36%	1.82%	2.29%	1.70%	1.52%	1.40%
Total Shareholder Return	3.36%	1.82%	2.29%	1.70%	1.52%	1.40%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).